Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 8/17/2025

Infections in Transplant Recipients

Introduction to Nocardia Infection

  • Nocardiosis primarily affects immunocompromised patients, including organ transplant recipients and individuals on immunosuppressive or anti-TNF therapy, with a significant impact on prognosis 1, 2

Diagnosis of Nocardia Infection

  • The Infectious Diseases Society of America recommends aerobic bacterial culture as the primary diagnostic method, using culture plates incubated for up to 7 days and buffered charcoal yeast extract (BCYE) agar to enhance recovery of Nocardia 3
  • Additional diagnostic methods include Calcofluor-KOH stain for certain specimens, modified Ziehl-Neelsen staining, microbiological culture, and molecular biology techniques for species identification 1, 4
  • Notification of the laboratory when Nocardia is suspected is crucial for proper processing and extended incubation, as recommended by the Infectious Diseases Society of America 3

Clinical Manifestations of Nocardia Infection

  • The most common clinical manifestations of nocardiosis include pulmonary infection, cutaneous lesions, central nervous system dissemination, and disseminated infection in severe cases 1
  • Dissemination to the central nervous system (CNS) occurs in up to 40% of transplant recipients with Nocardia infection, significantly worsening prognosis and requiring longer treatment duration, according to the American Society of Transplantation guidelines 2

Treatment of Nocardia Infection

  • The American College of Physicians recommends trimetoprim-sulfametoxazol (TMP-SMX) as the treatment of choice for nocardiosis, with a duration of 6 to 24 months depending on the extent of the infection and the patient's immune status 1
  • Treatment duration varies depending on the severity of the infection:

    Infection Type Treatment Duration
    Localized cutaneous infection 3-6 months
    Pulmonary infection 6-12 months
    Central nervous system or disseminated infection 12-24 months

    1

  • Surgical debridement is recommended for necrotic nodules, large subcutaneous abscesses, and obtaining samples for culture and sensitivity testing 1
  • Antimicrobial sensitivity testing is crucial, with the preferred method being broth microdilution, to adjust treatment according to sensitivity results 1

Management and Prevention of Nocardia Infection

  • Regular clinical evaluation, imaging studies to assess response, monitoring for antibiotic adverse effects, and considering periodic renal and hepatic function tests are essential for managing nocardiosis 1
  • Preventive measures include avoiding contact between soil and broken skin, avoiding inhalation of contaminated soil dust, and considering prophylaxis with TMP-SMX in high-risk patients 5
  • In patients with inflammatory bowel disease or rheumatological conditions on anti-TNF therapy, temporarily suspend immunosuppressive therapy until the active infection is resolved, and consider restarting therapy in consultation with an infectious disease specialist 5